SCHEMBL10075825

SCHEMBL10075825

CC(=O)O/N=C(\C)C(=O)c1ccc(Sc2ccc(C(=O)OCC(O)COc3ccccc3)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.51
MAPT P10636 3/20 0.45
ADRB2 P07550 6/20 0.41
ADRB1 P08588 6/20 0.41
ADRB3 P13945 6/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ABCB1 P08183 2/20 0.37
ALDH1A1 P00352 2/20 0.37
USP2 O75604 1/20 0.36
CYP2D6 P10635 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10075827 0.85 MAPT (0.45) KMT2AMEN1MAPTLMNAPOLB
SCHEMBL10075780 0.85 ALDH1A1 (0.39) KMT2AMEN1MAPTADRB2ADRB1
SCHEMBL10075768 0.83 L3MBTL1 (0.41) KMT2AMAPTADRB2ADRB1ADRB3
SCHEMBL10075792 0.82 ABCB1 (0.39) KMT2AMEN1MAPTLMNAPOLB
SCHEMBL16019156 0.79 HPGD (0.56) KMT2AMAPTLMNAPOLBALDH1A1
SCHEMBL19795435 0.79 HPGD (0.56) KMT2AMAPTLMNAPOLBALDH1A1
SCHEMBL10075710 0.78 L3MBTL1 (0.45) KMT2AMEN1MAPTLMNAPOLB
SCHEMBL10075797 0.78 KMT2A (0.36) KMT2AMEN1MAPTADRB2ADRB1
SCHEMBL12865769 0.78 MEN1 (0.77) KMT2AMEN1MAPTADRB2ADRB1
SCHEMBL10075808 0.76 L3MBTL1 (0.41) KMT2ALMNAALDH1A1CYP2D6L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2586827-B1 CURABLE RESIN COMPOSITION ADEKA CORP (JP) 2017-12-27 EP disclosed
US-8735511-B2 Curing resin composition ADEKA CORPORATION (JP) 2014-05-27 US disclosed
US-8735511-B2 Curing resin composition ADEKA CORPORATION (JP) 2014-05-27 US disclosed
EP-2586827-A1 CURABLE RESIN COMPOSITION Adeka Corporation (JP) 2013-05-01 EP disclosed
US-20120115972-A1 CURING RESIN COMPOSITION ADEKA CORPORATION (JP) 2012-05-10 US disclosed
US-20120115972-A1 CURING RESIN COMPOSITION ADEKA CORPORATION (JP) 2012-05-10 US disclosed
US-8148045-B2 Oxime ester compound and photopolymerization initiator containing the same ADEKA CORPORATION (JP) 2012-04-03 US disclosed
US-8148045-B2 Oxime ester compound and photopolymerization initiator containing the same ADEKA CORPORATION (JP) 2012-04-03 US disclosed
US-20110129778-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME ADEKA CORPORATION (JP) 2011-06-02 US disclosed
US-20110129778-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME ADEKA CORPORATION (JP) 2011-06-02 US disclosed
EP-2327689-A1 Oxime ester compound and photopolymerization initiator containing the same Adeka Corporation (JP) 2011-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110129778-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME OXER1, OR10J3, CDK11B KMT2A 3531/4885MEN1 4679/4885MAPT 3494/4885
US-20120115972-A1 CURING RESIN COMPOSITION LTA, LOXL1, PLOD2 KMT2A 247/4885MEN1 4864/4885MAPT 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.